If you would like to indulge in psychedelics but aren’t big on meeting up with people, queue social distancing, then having an app that stands watch during your trip is the next best option.
One such company that focuses on this, is Field Trip Health. It centers on psychedelic-assisted therapy and is about to launch their Trip app in the coming weeks. This company, like many others that are coming up, belongs to a growing group of for-profit firms that are using psychedelic drugs such as Ketamine, MDMA and psilocybin to help treat and manage anxiety, depression and other mental disorders.
The company operates legally and is fully aware that psychedelic drugs are still illegal in most states and most countries. So, instead of waiting for the legalization of psychedelics, the company is treating certain patients with Ketamine, which is an FDA approved dissociative drug.
Ketamine has had many uses in the past; a horse tranquilizer and a party drug. Additionally, it is also used as an anti-inflammatory medication and as an anesthetic. Unlike mushrooms, it may not always cause a hallucinogenic experience but if the right dosage is administered, an individual may be put in a dissociative, trance-like state.
Additionally, recent research and studies from the National Institute of Mental Health and Yale have discovered that ketamine is a fast-acting drug option to help in treating depression.
Field Trip administers ketamine in their clinics only. Hope is not lost though as other companies that are researching psychedelic drugs such as Mindbloom, also provide ketamine sessions in their clinics and at-home treatment options as well. The home treatment option allows one to receive their ketamine pills through mail.
The Trip app asks various questions that ensure that you, the user remain supervised, even in the comfort of your home. These may include questions like:
- What type of Trip are you taking? This has a variety of options to type in
- How far are you looking to go? This mainly represents the amount of the psychedelic drug that you plan to ingest.
Additionally, the app provides different features such as:
- Five calming soundtracks
- Questions that inquire on your state of mind
- Recording options on the app that allow an individual to take audio notes. This is particularly helpful if you’d prefer it to journaling
The app is a well-equipped guide that helps an individual as they journey through their consciousness. It would be a lie to say that most people are not using drugs recreationally or self-medicating in their homes. At least by using the Trip app, one is offered instructions and additional features that ensure the trip is pleasant and one can record their feelings and thoughts, which helps them progress in the treatment of their disorder.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
